Fernandes P D, Guimarães J A, Assreuy J
Departamento de Farmacologia Básica e Clínica, Universidade Federal do Rio de Janeiro, Brasil.
Agents Actions. 1991 Mar;32(3-4):182-7. doi: 10.1007/BF01980871.
We have previously shown that KPP, a kinin potentiating peptide generated by tryptic digestion of human plasma proteins potentiated kinin effects on isolated smooth muscle preparations like guinea-pig ileum with high potency and specificity. We also obtained evidence suggesting that, unlike other potentiating peptides, KPP exerts its effect by a mechanism different from the inhibition of kinin metabolism by angiotensin converting enzyme, neutral endopeptidase and kininase I. Here we show the potentiating effect of KPP and of BPP9a, a potentiator derived from snake venom, towards the rat paw edema induced by bradykinin (BK). Our results show that: a) KPP is 25-fold more active than BPP9a in potentiating rat paw edema elicited by BK: b) like BPP9a, KPP is specific in potentiating kinin-induced edema, being ineffective in potentiating edema induced by histamine or serotonin; and c) DesArg9-BK (DABK) elicits a small edematogenic response which can be potentiated by both KPP and BPP9a.
我们之前已经表明,激肽增强肽(KPP)是通过对人血浆蛋白进行胰蛋白酶消化产生的一种激肽增强肽,它能高效且特异地增强激肽对离体平滑肌制剂(如豚鼠回肠)的作用。我们还获得了证据,表明与其他增强肽不同,KPP发挥作用的机制不同于通过抑制血管紧张素转换酶、中性内肽酶和激肽酶I对激肽的代谢。在此,我们展示了KPP和BPP9a(一种源自蛇毒的增强剂)对缓激肽(BK)诱导的大鼠足爪水肿的增强作用。我们的结果表明:a)在增强BK引起的大鼠足爪水肿方面,KPP的活性比BPP9a高25倍;b)与BPP9a一样,KPP在增强激肽诱导的水肿方面具有特异性,对组胺或5-羟色胺诱导的水肿无增强作用;c)去精氨酸9-缓激肽(DABK)引发的致水肿反应较小,KPP和BPP9a均可增强该反应。